FDA Approves Icotyde for Moderate-to-Severe Plaque Psoriasis
The FDA has approved Icotyde for moderate-to-severe plaque psoriasis in adults and adolescents, expanding systemic options for dermatologists treating pediatric patients.
Topic
Adolescent Dermatology
Topic